SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-430207
Filing Date
2013-11-06
Accepted
2013-11-06 16:36:11
Documents
3
Period of Report
2013-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d623924d8k.htm 8-K 16749
2 EX-99.1 d623924dex991.htm EX-99.1 8336
3 GRAPHIC g623924img002.jpg GRAPHIC 11089
  Complete submission text file 0001193125-13-430207.txt   41841
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 131196929
SIC: 2835 In Vitro & In Vivo Diagnostic Substances